Nan Young Lee

750 total citations
41 papers, 545 citations indexed

About

Nan Young Lee is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Nan Young Lee has authored 41 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 13 papers in Immunology and 9 papers in Oncology. Recurrent topics in Nan Young Lee's work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (9 papers) and Immune Cell Function and Interaction (9 papers). Nan Young Lee is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (9 papers) and Immune Cell Function and Interaction (9 papers). Nan Young Lee collaborates with scholars based in South Korea, Canada and Panama. Nan Young Lee's co-authors include Sang Kyun Sohn, Jang Soo Suh, Jong Gwang Kim, Kyu Bo Lee, Jin Ho Baek, Dong Hwan Kim, Dong Hwan Kim, Dong Hwan Kim, Kun Soo Lee and Young Rok and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Nan Young Lee

39 papers receiving 535 citations

Peers

Nan Young Lee
Nan Young Lee
Citations per year, relative to Nan Young Lee Nan Young Lee (= 1×) peers Alice Garnier

Countries citing papers authored by Nan Young Lee

Since Specialization
Citations

This map shows the geographic impact of Nan Young Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Young Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Young Lee more than expected).

Fields of papers citing papers by Nan Young Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan Young Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Young Lee. The network helps show where Nan Young Lee may publish in the future.

Co-authorship network of co-authors of Nan Young Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Nan Young Lee. A scholar is included among the top collaborators of Nan Young Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan Young Lee. Nan Young Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Nan Young, et al.. (2024). Raynaud’s Phenomenon: A Current Update on Pathogenesis, Diagnostic Workup, and Treatment. Vascular Specialist International. 40. 26–26. 5 indexed citations
2.
Lee, Nan Young, et al.. (2024). Syndecan-1 Plays a Role in the Pathogenesis of Sjögren’s Disease by Inducing B-Cell Chemotaxis through CXCL13–Heparan Sulfate Interaction. International Journal of Molecular Sciences. 25(17). 9375–9375. 1 indexed citations
3.
Bae, Sohyun, Ki Tae Kwon, Soyoon Hwang, et al.. (2023). Analysis of microbiological tests in patients withholding or withdrawing life-sustaining treatment at the end stage of life in 2 Korean hospitals. Infection Control and Hospital Epidemiology. 45(2). 201–206. 1 indexed citations
5.
Lee, Yoon Hee, Gun Oh Chong, Nan Young Lee, et al.. (2022). Comparison of Survival Outcomes According toBRCA1/2Variant Type in High-grade Serous Ovarian Cancer. In Vivo. 36(4). 1903–1910. 1 indexed citations
6.
Lee, Jeeyeon, Ho Yong Park, Jin Hyang Jung, et al.. (2022). Feasibility of targeted cascade genetic testing in the family members of BRCA1/2 gene pathogenic variant/likely pathogenic variant carriers. Scientific Reports. 12(1). 1842–1842. 7 indexed citations
7.
Park, Jong Pil, et al.. (2020). A Study on the Usefulness of Postmortem Diabetes Mellitus-Related Tests. Korean Journal of Legal Medicine. 44(4). 150–156.
8.
Won, Dong Il, Nan Young Lee, Jeong‐Hoon Lim, et al.. (2020). Natural soluble human leukocyte antigen class I in donor serum neutralizes donor-specific HLA alloantibodies in recipient serum. Blood Research. 55(2). 91–98. 3 indexed citations
10.
Woo, Young Min, Se‐Hwa Kim, Jongho Park, et al.. (2019). Evidence that 6q25.1 variant rs6931104 confers susceptibility to chronic myeloid leukemia through RMND1 regulation. PLoS ONE. 14(6). e0218968–e0218968. 2 indexed citations
11.
Song, Sumin, Hyun‐Ha Chang, Sang‐Ah Lee, et al.. (2019). Ten Cases of Taenia saginata Infection Confirmed by Analysis of the Internal Transcribed Spacer 1 rDNA Region in the Republic of Korea. Korean Journal of Parasitology. 57(4). 417–422. 4 indexed citations
12.
Lee, Nan Young, et al.. (2010). EFFECT OF FLUORIDE IN NATURAL POLYMER ON ENAMEL DEMINERALIZATION. THE JOURNAL OF THE KOREAN ACADEMY OF PEDTATRIC DENTISTRY. 37(1). 35–43. 2 indexed citations
14.
Lee, Je‐Jung, Dong Hwan Kim, Nan Young Lee, et al.. (2007). Interleukin‐10 gene polymorphism influences the prognosis of T‐cell non‐Hodgkin lymphomas. British Journal of Haematology. 137(4). 329–336. 25 indexed citations
15.
Kim, Dong Hwan, et al.. (2007). Vascular endothelial growth factor (VEGF) gene (VEGFA) polymorphism can predict the prognosis in acute myeloid leukaemia patients. British Journal of Haematology. 140(1). 71–79. 30 indexed citations
17.
Kim, Dong Hwan, Nan Young Lee, Jin Ho Baek, et al.. (2006). Prognostic scoring model based on multi-drug resistance status and cytogenetics in adult patients with acute myeloid leukemia. Leukemia & lymphoma. 47(3). 461–467. 19 indexed citations
19.
20.
Lee, Nan Young, et al.. (2001). Elecsys 2010을 이용한 혈청 CTX와 osteocalcin 검사의 평가. The Korean Journal of Laboratory Medicine. 21(6). 459–464. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026